OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls
Margaret Hahn, Tom Wolever, Tamara Arenovich, et al.
Journal of Clinical Psychopharmacology (2013) Vol. 33, Iss. 6, pp. 740-746
Closed Access | Times Cited: 72
Margaret Hahn, Tom Wolever, Tamara Arenovich, et al.
Journal of Clinical Psychopharmacology (2013) Vol. 33, Iss. 6, pp. 740-746
Closed Access | Times Cited: 72
Showing 51-75 of 72 citing articles:
Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia
Alessandro Bonifazi, Michael P. Ellenberger, Zachary J. Farino, et al.
Diabetes (2024) Vol. 73, Iss. 9, pp. 1411-1425
Open Access | Times Cited: 1
Alessandro Bonifazi, Michael P. Ellenberger, Zachary J. Farino, et al.
Diabetes (2024) Vol. 73, Iss. 9, pp. 1411-1425
Open Access | Times Cited: 1
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis
Kyle J. Burghardt, Wasym Mando, Berhane Seyoum, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 42, Iss. 6, pp. 504-513
Open Access | Times Cited: 7
Kyle J. Burghardt, Wasym Mando, Berhane Seyoum, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 42, Iss. 6, pp. 504-513
Open Access | Times Cited: 7
Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats
Ching-Ping Yang, Yayu Wang, Shih‐Yi Lin, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 640-640
Open Access | Times Cited: 10
Ching-Ping Yang, Yayu Wang, Shih‐Yi Lin, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 640-640
Open Access | Times Cited: 10
Dietary Fructose and GLUT5 Transporter Activity Contribute to Antipsychotic-Induced Weight Gain
Caroline B. Palavicino‐Maggio, Eldo V. Kuzhikandathil
Schizophrenia Bulletin (2016) Vol. 42, Iss. 5, pp. 1270-1279
Open Access | Times Cited: 8
Caroline B. Palavicino‐Maggio, Eldo V. Kuzhikandathil
Schizophrenia Bulletin (2016) Vol. 42, Iss. 5, pp. 1270-1279
Open Access | Times Cited: 8
Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review
Emily Chen Chen Smith, Emily Au, Susana Pereira, et al.
Psychiatry Research (2023) Vol. 328, pp. 115472-115472
Closed Access | Times Cited: 3
Emily Chen Chen Smith, Emily Au, Susana Pereira, et al.
Psychiatry Research (2023) Vol. 328, pp. 115472-115472
Closed Access | Times Cited: 3
Psychopharmacology of agitation in acute psychotic and manic episodes
Sean R. Stetson, David N. Osser
Current Opinion in Psychiatry (2022) Vol. 35, Iss. 3, pp. 171-176
Closed Access | Times Cited: 5
Sean R. Stetson, David N. Osser
Current Opinion in Psychiatry (2022) Vol. 35, Iss. 3, pp. 171-176
Closed Access | Times Cited: 5
Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration
Jeffrey Guina, Sayon Roy, Ankur Gupta, et al.
Human Psychopharmacology Clinical and Experimental (2017) Vol. 32, Iss. 4, pp. e2604-e2604
Closed Access | Times Cited: 6
Jeffrey Guina, Sayon Roy, Ankur Gupta, et al.
Human Psychopharmacology Clinical and Experimental (2017) Vol. 32, Iss. 4, pp. e2604-e2604
Closed Access | Times Cited: 6
Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism
Kyle D. Medak, Alyssa J. Weber, Hesham Shamshoum, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Kyle D. Medak, Alyssa J. Weber, Hesham Shamshoum, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Voluntary physical activity protects against olanzapine-induced hyperglycemia
Hesham Shamshoum, Greg L. McKie, Kyle D. Medak, et al.
Journal of Applied Physiology (2020) Vol. 130, Iss. 2, pp. 466-478
Closed Access | Times Cited: 5
Hesham Shamshoum, Greg L. McKie, Kyle D. Medak, et al.
Journal of Applied Physiology (2020) Vol. 130, Iss. 2, pp. 466-478
Closed Access | Times Cited: 5
Assessment of lipid response to acute olanzapine administration in healthy adults
Avital Nahmias, Priska Stahel, Satya Dash
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 2
Open Access | Times Cited: 4
Avital Nahmias, Priska Stahel, Satya Dash
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 2
Open Access | Times Cited: 4
Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia
Alessandro Bonifazi, Michael P. Ellenberger, Zachary J. Farino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alessandro Bonifazi, Michael P. Ellenberger, Zachary J. Farino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Second-generation antipsychotic drugs and their impact on adipose tissue
Patricia Rada, Vítor Ferreira, Ángela M. Valverde
Anales de la Real Academia Nacional de Farmacia (2024), Iss. 90(01), pp. 21-44
Open Access
Patricia Rada, Vítor Ferreira, Ángela M. Valverde
Anales de la Real Academia Nacional de Farmacia (2024), Iss. 90(01), pp. 21-44
Open Access
Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics
Jessie N. Rice, Ujjwal Ramtekkar
Medical Sciences (2020) Vol. 8, Iss. 3, pp. 34-34
Open Access | Times Cited: 3
Jessie N. Rice, Ujjwal Ramtekkar
Medical Sciences (2020) Vol. 8, Iss. 3, pp. 34-34
Open Access | Times Cited: 3
Diagnosis and management of hyperglycaemia in patients treated with antipsychotic drugs
Marcin Kosmalski, Monika Różycka-Kosmalska, Marcin Basiak, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 5, pp. 872-884
Open Access | Times Cited: 2
Marcin Kosmalski, Monika Różycka-Kosmalska, Marcin Basiak, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 5, pp. 872-884
Open Access | Times Cited: 2
Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls
Nicolette Stogios, Laurie Hamel, Emily R. Smith, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0277211-e0277211
Open Access | Times Cited: 2
Nicolette Stogios, Laurie Hamel, Emily R. Smith, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0277211-e0277211
Open Access | Times Cited: 2
Atypical Antipsychotic Medications Disrupt the Cardio-Metabolic and Cardio-Immune Axes
Bahman Rostama, Meghan May, KL Houseknecht
Interventional Cardiology (2020) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Bahman Rostama, Meghan May, KL Houseknecht
Interventional Cardiology (2020) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Probiotic supplements reduce antipsychotic-induced metabolic disturbances in drug-naïve first-episode schizophrenia
Dongyu Kang, Fengyu Zhang, Ye Yang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Dongyu Kang, Fengyu Zhang, Ye Yang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
The use of melatonin to mitigate the adverse metabolic side effects of antipsychotics
Francisco Romo‐Nava, Ruud M. Buijs, Susan L. McElroy
Handbook of clinical neurology (2021), pp. 371-382
Closed Access | Times Cited: 1
Francisco Romo‐Nava, Ruud M. Buijs, Susan L. McElroy
Handbook of clinical neurology (2021), pp. 371-382
Closed Access | Times Cited: 1
Nicotinamide Mononucleotide in the Context of Elevated Plasma Levels of Free Fatty Acids Improves Glucose Tolerance by Decreasing Insulin Clearance
Ashraf Nahle
(2016)
Closed Access
Ashraf Nahle
(2016)
Closed Access
Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine
Kyle D. Medak, Stewart Jeromson, A. Bellucci, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108628-108628
Open Access
Kyle D. Medak, Stewart Jeromson, A. Bellucci, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108628-108628
Open Access
Investigating the Gut Microbiome, Metabolomic Signatures, and Metabolic Dysfunction in Antipsychotic Naïve Patients
Kenya A. Costa-Dookhan
(2020)
Closed Access
Kenya A. Costa-Dookhan
(2020)
Closed Access
Psychotische Störungen, Antipsychotika und Diabetes
Marion Schullerus, Anke Ruetz, Julia Reiff, et al.
Der Diabetologe (2021) Vol. 17, Iss. 7, pp. 712-720
Closed Access
Marion Schullerus, Anke Ruetz, Julia Reiff, et al.
Der Diabetologe (2021) Vol. 17, Iss. 7, pp. 712-720
Closed Access
